share_log

Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Short Interest Update

Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Short Interest Update

奥托再生技术公司(OTCMKTS:ORIF)空头股数更新
kopsource ·  2022/09/14 12:52

Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF – Get Rating) saw a large drop in short interest in August. As of August 31st, there was short interest totalling 100 shares, a drop of 93.3% from the August 15th total of 1,500 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

奥托再生科技股份有限公司(OTCMKTS:ORTIF-GET Rating)8月份空头股数股价大幅下跌。截至8月31日,空头股数共有100股,与8月15日的1500股相比,下降了93.3%。以日均成交量0股计算,目前短息比率为∞天。

Ortho Regenerative Technologies Price Performance

正射再生技术性价比

ORTIF stock remained flat at $0.20 during mid-day trading on Wednesday. The company has a market capitalization of $6.86 million, a P/E ratio of -1.78 and a beta of -1.16. The business has a fifty day simple moving average of $0.20 and a 200 day simple moving average of $0.19. Ortho Regenerative Technologies has a 12-month low of $0.13 and a 12-month high of $0.45.

在周三午盘交易中,ORTIF股价持平于0.20美元。该公司市值686万美元,市盈率为-1.78,贝塔系数为-1.16。该业务的50日简单移动均线切入位为0.20美元,200日简单移动均线切入位为0.19美元。Ortho Regenerative Technologies的12个月低点为0.13美元,12个月高位为0.45美元。

Get
到达
Ortho Regenerative Technologies
正畸再生技术
alerts:
警报:

Ortho Regenerative Technologies (OTCMKTS:ORTIF – Get Rating) last issued its earnings results on Thursday, June 23rd. The company reported ($0.02) earnings per share for the quarter. Analysts anticipate that Ortho Regenerative Technologies will post -0.08 earnings per share for the current fiscal year.

Ortho Regenerative Technologies(OTCMKTS:ORTIF-GET Rating)最近一次发布收益报告是在6月23日(星期四)。该公司公布了本季度每股收益(0.02美元)。分析师预计,Ortho Regenerative Technologies本财年的每股收益将为0.08美元。

Wall Street Analysts Forecast Growth

华尔街分析师预测经济增长

Separately, Noble Financial started coverage on Ortho Regenerative Technologies in a research report on Monday, July 11th. They issued an "outperform" rating and a C$1.35 price target on the stock.
另外,来宝金融在7月11日星期一的一份研究报告中开始报道Ortho Regenerative Technologies。他们对该股给予了“跑赢大盘”的评级和1.35加元的目标价。

Ortho Regenerative Technologies Company Profile

Ortho再生技术公司简介

(Get Rating)

(获取评级)

Ortho Regenerative Technologies Inc, an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration.

Ortho Regenerative Technologies Inc是一家整形外科和运动医学生物制剂公司,致力于研究和开发新型治疗性软组织修复技术,以提高加拿大运动医学手术的成功率。它开发了用于肩袖修复的Ortho-R配方、用于半月板修复的生物聚合物Ortho-M、用于关节软骨修复的生物聚合物Ortho-C、用于骨关节炎愈合的生物聚合物Ortho-V以及用于肌腱愈合和再生的生物聚合物配方Ortho-T。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on Ortho Regenerative Technologies (ORTIF)
  • Is Lyft Going To Make It As Acquisition Rumors Swirl?
  • Can Health Drink Maker Celsius Outrun Its Monster Rival?
  • It's Time To Embrace Another 25% Decline In The S&P 500
  • Four Cheap Stocks With Interesting Insider Activity
  • These 3 Reports Will Tell Us Much About the Current Economy
  • 免费获取StockNews.com关于正畸再生技术的研究报告(ORTIF)
  • 随着收购传言的甚嚣尘上,Lyft能否成功?
  • 健康饮料制造商Celsius能否超越其Monster竞争对手?
  • 现在是时候接受标准普尔500指数再下跌25%的时候了
  • 具有有趣内幕活动的四只廉价股票
  • 这三份报告将告诉我们许多关于当前经济的情况。

Receive News & Ratings for Ortho Regenerative Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Regenerative Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

接受《正畸再生技术日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Ortho再生技术公司和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发